References: Antithrombotic therapy after transcatheter aortic valve implantation

  • Greco A, Capodanno D. Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status. Interv Cardiol 2020;15:e02. https://www.ncbi.nlm.nih.gov/pubmed/32382318
  • Mahalwar G, Kumar A, Majmundar M, Adebolu O, Yendamuri R, Lao N, et al. Antithrombotic Strategy After Transcatheter Aortic Valve Replacement: A Network Meta-Analysis. Curr Probl Cardiol 2022:101348. https://www.ncbi.nlm.nih.gov/pubmed/35944749
  • Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2021;60(4):727-800. https://www.ncbi.nlm.nih.gov/pubmed/34453161
  • Writing Committee M, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, 3rd, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;77(4):450-500. https://www.ncbi.nlm.nih.gov/pubmed/33342587